WVE

Wave Life Sciences Ltd. Ordinary Shares (WVE)

About Wave Life Sciences Ltd. Ordinary Shares (WVE)

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Details

Daily high

$10.10

Daily low

$9.50

Price at open

$9.67

52 Week High

$16.74

52 Week Low

$4.25

Market cap

1.5B

Dividend yield

0.00%

Volume

911,447

Avg. volume

1.1M

P/E ratio

-12.67

Wave Life Sciences Ltd. Ordinary Shares News